1-ethyl-3-[7-[1-(2-methoxyethyl)-2-oxo-4-pyridinyl]-5-(5-methylpyrimidin-2-yl)imidazo[1,2-a]pyridin-2-yl]urea
C23H25N7O3 — CID 45484817
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-ethyl-3-[7-[1-(2-methoxyethyl)-2-oxo-4-pyridinyl]-5-(5-methylpyrimidin-2-yl)imidazo[1,2-a]pyridin-2-yl]urea
1-ethyl-3-[7-[1-(2-methoxyethyl)-2-oxo-4-pyridinyl]-5-(5-methylpyrimidin-2-yl)imidazo[1,2-a]pyridin-2-yl]urea (PubChem CID 45484817) has the molecular formula C23H25N7O3 and a molecular weight of 447.50 g/mol. Its IUPAC name is 1-ethyl-3-[7-[1-(2-methoxyethyl)-2-oxo-4-pyridinyl]-5-(5-methylpyrimidin-2-yl)imidazo[1,2-a]pyridin-2-yl]urea.
Molecular Properties
| Compound Name | 1-ethyl-3-[7-[1-(2-methoxyethyl)-2-oxo-4-pyridinyl]-5-(5-methylpyrimidin-2-yl)imidazo[1,2-a]pyridin-2-yl]urea |
|---|---|
| PubChem CID | 45484817 |
| Molecular Formula | C23H25N7O3 |
| Molecular Weight | 447.50 g/mol |
| Exact Mass | 447.20 |
| IUPAC Name | 1-ethyl-3-[7-[1-(2-methoxyethyl)-2-oxo-4-pyridinyl]-5-(5-methylpyrimidin-2-yl)imidazo[1,2-a]pyridin-2-yl]urea |
| SMILES | CCNC(=O)Nc1cn2c(-c3ncc(C)cn3)cc(-c3ccn(CCOC)c(=O)c3)cc2n1 |
| InChI | InChI=1S/C23H25N7O3/c1-4-24-23(32)28-19-14-30-18(22-25-12-15(2)13-26-22)9-17(10-20(30)27-19)16-5-6-29(7-8-33-3)21(31)11-16/h5-6,9-14H,4,7-8H2,1-3H3,(H2,24,28,32) |
| InChIKey | XRJJMGUVFQTPKV-UHFFFAOYSA-N |
| XLogP | 2.72 |
| TPSA | 115.44 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 447.50 |
| LogP ≤ 5 | 2.72 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 45484817 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.